Mycn Conditional Knockout mouse models

Encoding N-Myc, Mycn is the mouse ortholog of human MYCN and produces a basic helix-loop-helix leucine zipper factor that heterodimerizes with Max, occupies E-box elements, and drives ribosome biogenesis and cell cycle programs in neural crest, neuroblast, and cerebellar progenitors; like c-Myc it carries the Thr58 and Ser62 phosphodegron read by Fbxw7, but Aurora kinase A binding stabilizes the protein against that pathway, which is the mechanistic basis for Aurora A inhibitor strategies in MYCN-amplified disease. Genomic amplification defines high-risk neuroblastoma and also occurs in medulloblastoma and neuroendocrine prostate cancer. Homozygous nulls die in mid-gestation with neural, cardiac, and lung defects, so conditional deletion is required for progenitor studies, whereas lineage-restricted overexpression modeled on tyrosine hydroxylase promoter-driven designs remains the standard tumor-initiating allele, and a Thr58Ala knockin isolates degron control from expression level. Myc can substitute at the endogenous locus, so paralog dosage and driver specificity govern the phenotype.

Tissue restricted knockout of Mycn keeps wild type function everywhere else. Breeding is often more robust, and the setup mirrors patient biology where mutations arise in a subset of cells.